Key result
Hirudin attenuates Ang II-induced myocardial fibroblast proliferation and fibrosis via suppressing the ERK1/2 pathway.
Why the study?
Does hirudin prevent Ang II-induced myocardial fibrosis in murine myocardial fibroblasts?
Does hirudin prevent Ang II-induced myocardial fibrosis in murine myocardial fibroblasts?
p-value: p=<0.05
Hirudin attenuates Ang II-induced myocardial fibrosis in vitro by inhibiting oxidative stress and the ERK1/2 pathway, suggesting potential therapeutic value for heart disease.
Hypothesis-generating for hirudin in myocardial fibrosis; leaves open any clinical role in human heart disease.
BACKGROUND Myocardial fibrosis is closely related to all types of cardiovascular diseases. Hirudin is widely used in the prevention and treatment of cardiovascular diseases and cancers. In this study, we examined the potential role(s) and mechanism of hirudin in angiotensin II (Ang II)-induced myocardial fibrosis. MATERIAL AND METHODS The viability of myocardial fibroblasts, and reactive oxygen species (ROS) rates were measured respectively using cell counting kit-8 (CCK-8) and flow cytometry. Malondialdehyde (MDA) content, the activities of lactate dehydrogenase (LDH), and superoxide dismutase (SOD) were detected by the respective kits. The mRNA and protein levels of fibrosis-related factors were separately assessed by qRT-PCR and western blot. RESULTS Our data revealed that hirudin suppressed the viability of myocardial fibroblasts, and that it relieved the proliferation induced by Ang II in a dose-dependent manner. We also found that hirudin reduced ROS production, LDH activity, and MDA content; however, it enhanced SOD activity. Moreover, while hirudin significantly downregulated the levels of matrix metalloproteinase-2 (MMP-2), MMP-9, fibronectin (FN), transforming growth factor beta 1 (TGF-β1), collagen-I (COL-I), and COL-III, it upregulated the expression level of tissue inhibitor of metalloproteinases-2 (TIMP-2). Furthermore, phosphorylated extracellular signal-regulated kinase1/2 (p-ERK1/2) was decreased by hirudin, compared to the Ang-II group. CONCLUSIONS Hirudin depressed Ang II-induced myocardial fibroblasts via inhibiting oxidative stress, regulating fibrosis-related factors, and repressing the ERK1/2 pathway.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2018) studied Ang II-induced myocardial fibrosis. Hirudin vs. Ang II alone or PBS was evaluated on Cell viability, oxidative stress markers, and fibrosis-related factors (p=<0.05). Hirudin depressed Ang II-induced myocardial fibroblasts by inhibiting oxidative stress, regulating fibrosis-related factors, and repressing the ERK1/2 pathway.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: